Summary
Jacob Martin is an analytical development leader with 17 years of bioengineering R&D and 24 years of professional experience, currently directing Biochemistry & Microbiology for high-concentration protein therapeutics at Halozyme in Cambridge. He has built and managed cross-functional teams delivering analytical strategies and GMP-aligned assays for complex biologics including EVs, AAV, adenovirus, and recombinant proteins, and has hands-on expertise in chromatography, capillary electrophoresis, particle analysis, and endotoxin/sterility testing. Jacob has led programs from preclinical formulation through Phase 1 clinical trial material production in partnership with big-pharma and CMOs, and previously advanced oral delivery platforms and single-particle characterization methods (cryo-EM, MRPS, CDMS). He pairs rigorous technical depth—PhD-trained chemical engineer with peer-reviewed publications in vaccine and nanoparticle research—with strong project and people management, and a track record of translating novel platform ideas into deployable development plans. Notably, he blends bench-scale innovation (e.g., engineered antibody reagents and novel nanoparticle assays) with operational oversight of USP-compliant testing and external vendor networks.
23 years of coding experience
8 years of employment as a software developer
Doctor of Philosophy (Ph.D.) Chemical Engineering, Doctor of Philosophy (Ph.D.) Chemical Engineering at Rensselaer Polytechnic Institute
Bachelor's Degree Chemical Engineering, Bachelor's Degree Chemical Engineering at University of Connecticut